Floatz logo

ENGINEERED TOXIN BODY (ETB) COMPRISING A CD20 SCFV AND A MODIFIED SHIGA-LIKE TOXIN A

Refractory Diffuse Large B-Cell Lymphoma

Molecular Templates, Inc.protein_peptidePhase 2Dormant
D
29/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
14/ 100
Competitive Position
81/ 100

Competitive context

108 Active assets in the Refractory Diffuse Large B-Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Selinexor
Chengdu Zenitar Biomedical Technology Co., Ltd
Phase 3BB
DEXAMETHASONE
City of Hope Medical Center
Phase 2/3BB
Ifosfamide
University of California, Davis
Phase 3BB
Cyclophosphamide
Nathan Denlinger
Phase 3BB
Axicabtagene Ciloleucel
Zhujiang Hospital
Phase 3BB

View all 50 →

Same molecule, other indications

ENGINEERED TOXIN BODY (ETB) COMPRISING A CD20 SCFV AND A MODIFIED SHIGA-LIKE TOXIN A is also rated in:

B-cell non-Hodgkin lymphomaDormant
D
Indicative ·
30 / 100
View asset →
chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
D
Indicative ·
30 / 100
View asset →
non-Hodgkin lymphomaDormant
D
Indicative ·
29 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →